Biolife Solutions Inc financial data

Symbol
BLFS on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3303 Monte Villa Parkway, Suite 310, Bothell, Washington
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CRYOMEDICAL SCIENCES INC (to 11/14/2002)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 288 % -7.63%
Quick Ratio 104 % +22.3%
Debt-to-equity 22.4 % +8.06%
Return On Assets -15.2 % +51.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46M shares +6.52%
Common Stock, Shares, Outstanding 45.7M shares +5.54%
Entity Public Float 774M USD +63.7%
Common Stock, Value, Issued 46K USD +6.98%
Weighted Average Number of Shares Outstanding, Basic 45.4M shares +5.59%
Weighted Average Number of Shares Outstanding, Diluted 45.4M shares +5.59%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 18.2M USD +19.8%
Selling and Marketing Expense 23.2M USD +0.14%
General and Administrative Expense 53.8M USD +5.56%
Costs and Expenses 205M USD -34.9%
Operating Income (Loss) -67.3M USD +55.5%
Nonoperating Income (Expense) 4.62M USD +516%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -62.7M USD +58.3%
Income Tax Expense (Benefit) 208K USD +42.4%
Net Income (Loss) Attributable to Parent -62.9M USD +56.9%
Earnings Per Share, Basic -1.42 USD/shares +58.6%
Earnings Per Share, Diluted -1.42 USD/shares +31.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.7M USD +55.4%
Cash, Cash Equivalents, and Short-term Investments 46.1M USD -19%
Accounts Receivable, after Allowance for Credit Loss, Current 18.6M USD -38.8%
Inventory, Net 43.4M USD +5.05%
Assets, Current 112M USD -15.9%
Property, Plant and Equipment, Net 21M USD -19.4%
Operating Lease, Right-of-Use Asset 10.8M USD -30.9%
Intangible Assets, Net (Excluding Goodwill) 20.2M USD -33.9%
Goodwill 225M USD 0%
Assets 402M USD -10%
Accounts Payable, Current 4.98M USD -67.9%
Accrued Liabilities, Current 4.25M USD +11.2%
Contract with Customer, Liability, Current 299K USD -29.1%
Liabilities, Current 38.7M USD -18.3%
Deferred Income Tax Liabilities, Net 193K USD -26.6%
Operating Lease, Liability, Noncurrent 12.6M USD -16.8%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 68.2M USD -22.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -566K USD -5.99%
Retained Earnings (Accumulated Deficit) -325M USD -24.8%
Stockholders' Equity Attributable to Parent 333M USD -6.9%
Liabilities and Equity 402M USD -10%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.48M USD -65%
Net Cash Provided by (Used in) Financing Activities -952K USD -69.4%
Net Cash Provided by (Used in) Investing Activities -221K USD -108%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 45.7M shares +5.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.7M USD +55.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 445K USD -10.5%
Deferred Tax Assets, Valuation Allowance 54.7M USD +36.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 56M USD +26.1%
Operating Lease, Liability 15.2M USD -15.5%
Depreciation 3.4M USD -1.25%
Payments to Acquire Property, Plant, and Equipment 6.38M USD -38.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -63M USD +56.9%
Lessee, Operating Lease, Liability, to be Paid 17.3M USD -16.8%
Property, Plant and Equipment, Gross 31.7M USD -11.2%
Operating Lease, Liability, Current 2.65M USD -8.98%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.57M USD -12.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.03M USD -10.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 5K USD -61.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.07M USD -25.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.28M USD -9.99%
Deferred Tax Assets, Operating Loss Carryforwards 35.5M USD +22%
Deferred Federal Income Tax Expense (Benefit) -62K USD +97.9%
Current Income Tax Expense (Benefit) 231K USD +6.94%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 954K USD +56.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.04M USD -10.4%
Additional Paid in Capital 653M USD
Current State and Local Tax Expense (Benefit) 46K USD +318%
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 4.64M USD -44.1%
Depreciation, Depletion and Amortization 1.36M USD -20.7%
Share-based Payment Arrangement, Expense 30.5M USD +11.7%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%